Weiyu Yao is a Principal Biostatistician specializing in HEOR/GMPA and Oncology at Servier since March 2023. Prior experience includes serving as a Clinical Data Scientist at EQRx from December 2021 to March 2023, where the company was acquired by Revolution Medicines. Previous roles also encompass Associate Research Scientist and Analyst in Precision HEOR at Precision Medicine Group from August 2019 to December 2021, earning a quarterly company PoP award, and Research Assistant at Harvard T.H. Chan School of Public Health from September 2017 to May 2019. Earlier experience includes a Data Analyst Intern position at Environmental Health & Engineering in the summer of 2018. Weiyu Yao holds a Master of Science in Risk and Decision Science from Harvard University and a Bachelor's degree in Environmental Science from China University of Geosciences, complemented by research experiences at University of California, Riverside, and University of Sydney.
This person is not in the org chart
This person is not in any teams
This person is not in any offices